Allegrini P R, Sauer D
Biology Research Laboratories, Pharmaceuticals Division, Ciba-Geigy Ltd., Basel, Switzerland.
Magn Reson Imaging. 1992;10(5):773-8. doi: 10.1016/0730-725x(92)90411-r.
Focal brain ischemia was induced by middle cerebral artery occlusion in the rat. The volume of cerebral damage was determined 2 days later by MRI in vivo and in the same animals histologically. The edema volume as measured by MRI and the histologically determined infarction was highly correlated. As a consequence, the neuroprotective effect of the N-methyl-D-aspartate (NMDA) receptor antagonists CGP 40116 and MK 801 were similar with both methods. Excitotoxic neurodegeneration in the rat striatum was induced by direct injection of quinolinic acid. The degree of damage was evaluated in vivo 1 day later by quantitative MRI, and 7 days later by measuring the activities of neuronal marker enzymes choline acetyltransferase and glutamic acid decarboxylase. Striatal damage assessed using the three approaches was highly correlated. Cerebroprotective efficacy of the NMDA receptor antagonist CGP 40116 was indistinguishable based on all methods. MRI was more reproducible than the enzymatic methods and was faster and simpler than histologic examination for routine analysis of excitotoxic damage and cerebroprotection in vivo in a pharmaceutical research environment.
通过大脑中动脉闭塞诱导大鼠局灶性脑缺血。2天后通过体内MRI和相同动物的组织学检查确定脑损伤体积。MRI测量的水肿体积与组织学确定的梗死高度相关。因此,N-甲基-D-天冬氨酸(NMDA)受体拮抗剂CGP 40116和MK 801的神经保护作用在两种方法中相似。通过直接注射喹啉酸诱导大鼠纹状体中的兴奋性毒性神经变性。1天后通过定量MRI在体内评估损伤程度,7天后通过测量神经元标记酶胆碱乙酰转移酶和谷氨酸脱羧酶的活性进行评估。使用这三种方法评估的纹状体损伤高度相关。基于所有方法,NMDA受体拮抗剂CGP 40116的脑保护功效没有差异。在药物研究环境中,对于体内兴奋性毒性损伤和脑保护的常规分析,MRI比酶法更具可重复性,并且比组织学检查更快、更简单。